Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with TARS: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
TARS
Tarsus Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
TARS
Tarsus Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
TARS, dashed
AMGN
Amgen Inc
Change
461.49
▼
−3.55%
· post 460.22
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
TARS
Tarsus Pharmaceuticals, Inc.
Change
67.46
▼
−2.33%
· post 66.23
Closed
Nov 5 '26
Mkt cap
$3.4B
Revenue
$195M
Q3 FY26
Revenue
$451M
FY25
vs
Compare
Closed
Nov 5 '26
AMGN
Amgen Inc
vs
TARS
Tarsus Pharmaceuticals, Inc.
461.49
▼
−3.55%
post 460.22
Price
67.46
▼
−2.33%
post 66.23
$249.0B
Mkt cap
$3.4B
Q3 FY26
$10.4B
Revenue
$195M
Q3 FY26
FY25
$36.8B
Revenue
$451M
FY25
Change
Change
AMGN
461.49
▼
−3.55%
vs
TARS
67.46
▼
−2.33%
Closed
Nov 5 '26